Menu
Back to Journals » OncoTargets and Therapy » Volume 13
Case report
A Novel ROS1-FBXL17 Fusion Co-Existing with CD74-ROS1 Fusion May Improve Sensitivity to Crizotinib and Prolong Progression-Free Survival of Patients with Lung Adenocarcinoma
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 4,387 | Dovepress* | 3,907+ | 624 | 4,531 | |
| PubMed Central* | 480 | 148 | 628 | ||
| Totals | 4,387 | 772 | 5,159 | ||
| *Since 10 November 2020 | |||||
| Total mentioned | Delicious | Others | |||
|---|---|---|---|---|---|
| 5 | 0 | 0 | 0 | 1 | 4 |
View citations on PubMed Central and Google Scholar